What is ImmunoMet worth?
$46.0Mlast known valuation
Free account
See the evidence behind this price
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for ImmunoMet
- ·The full record, as it builds
Create free account
No card required
Funding history
No rounds on record
No funding rounds for ImmunoMet are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Pro members can request priority coverage with a 48-hour turnaround.
How ImmunoMet's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For ImmunoMet, we compose those signals into the PA Mark — a weighted composite of 2 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →
Frequently asked
- What is ImmunoMet worth?
- ImmunoMet's implied valuation is $46.0M, based on the PA Mark composite price of about $21 per share as of Sep 2026.
- How much has ImmunoMet raised?
- ImmunoMet has raised $43.8M in total funding across its recorded rounds.